Drovelis Evrópusambandið - íslenska - EMA (European Medicines Agency)

drovelis

gedeon richter plc. - drospirenone, estetrol monohydrate - contraceptives, oral - hormón kynlíf og stillum kynfæri - oral contraceptive.

Lydisilka Evrópusambandið - íslenska - EMA (European Medicines Agency)

lydisilka

estetra sprl - estetrol monohydrate, drospirenone - contraceptives, oral - hormón kynlíf og stillum kynfæri - getnaðarvörn til inntöku. the decision to prescribe lydisilka should take into consideration the individual woman’s current risk factors, particularly those for venous thromboembolism (vte), and how the risk of vte with lydisilka compares with other combined hormonal contraceptives (chcs) (see sections 4. 3 and 4.

Okedi Evrópusambandið - íslenska - EMA (European Medicines Agency)

okedi

laboratorios farmacéuticos rovi, s.a. - risperidone - geðklofa - psycholeptics - treatment of schizophrenia in adults for whom tolerability and effectiveness has been established with oral risperidone.

Lamictal Tuggu-/dreifitafla 50 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

lamictal tuggu-/dreifitafla 50 mg

glaxosmithkline pharma a/s - lamotriginum inn - tuggu-/dreifitafla - 50 mg

Lamictal Tuggu-/dreifitafla 5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

lamictal tuggu-/dreifitafla 5 mg

glaxosmithkline pharma a/s - lamotriginum inn - tuggu-/dreifitafla - 5 mg

Lamictal Tuggu-/dreifitafla 25 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

lamictal tuggu-/dreifitafla 25 mg

glaxosmithkline pharma a/s - lamotriginum inn - tuggu-/dreifitafla - 25 mg

Lamictal Tuggu-/dreifitafla 200 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

lamictal tuggu-/dreifitafla 200 mg

glaxosmithkline pharma a/s - lamotriginum inn - tuggu-/dreifitafla - 200 mg